All Perspectives
8381 total results. Page 235 of 336.
The Food and Drug Administration has just announced that it will hold a Public Meeting on March 9, 2017 to discuss use of the term “healthy” in the labeling of human food products.
For the first time in nearly three decades, the Substance Abuse and Mental Health Services Administration (SAMHSA) has updated the regulations on the confidentiality of substance abuse treatment records found in 42 C.F.R. Part 2.
Arent Fox senior policy advisor and former Senator Byron Dorgan (D-ND) appeared on MSNBC along with former Senator Jim DeMint (R-SC) to discuss division in America in light of the Trump Administration with Greta Van Susteren.
Last month, Baxter International Inc. and Baxter Healthcare Corporation settled a qui tam False Claims Act case with the Department of Justice for $18 million. The settlement is not monumental in terms of the amount, but does highlight the unique theory of FCA liability.
In BC Law School Magazine’s winter edition, author Chad Konecky recounts the story of two Chinese American scientists accused of espionage by the US government. Peter Zeidenberg, a partner in Arent Fox's White Collar & Investigations practice, represented the scientists in both cases.
Please join us for a free webinar (noon-1:00 pm PT/3:00-4:00 pm ET) designed to help health care facilities prepare for the new CALOSHA regulation that addresses the threat of workplace violence.
The White House issued an executive order on January 30, 2017 requiring agencies and executive departments to "identify at least two existing regulations to be repealed" whenever they propose or promulgate a new regulation.
The CRFA (2016) voids a contract if it prohibits or restricts an individual from reviewing a seller's goods, services, or conduct.
New York attorneys Bill Tanenbaum and Randall Stempler published an article in Healthcare Business & Technology that explores how millennials view healthcare IT and more specifically, their concerns with the fragmented nature of medical online systems, and data security.
At a Silicon Valley IP symposium held at the Santa Clara University School of Law on Friday, February 3, presentations by in-house counsel and prosecutors highlighted the critical importance of trade secrets to technology companies.
A recent Bloomberg BNA article in the Health Care Daily Report “Former Tenet Executive Indicted in $400M Medicaid Kickback Scheme” describes an ongoing prosecution against a health care industry ex-executive.
Last week, Arent Fox LLP announced the recipients of the firm’s Marc L. Fleischaker and Albert E. Arent Pro Bono Awards, presented annually to lawyers and staff who demonstrate outstanding contributions to public service.
An Austrian hotel was a recent victim of a “ransomware” computer attack that disabled its electronic room key system and locked up its own computers. This demonstrates that hotel owners and managers should be sure IT agreements adequately address the risks of cyberattacks.
Food labeling litigation increased significantly last year, with many consumer groups alleging that products were misleadingly labeled and violated U.S. Food and Drug Administration labeling requirements.
The Federal Trade Commission has announced a proposed settlement and consent order in its investigation of a US-based water filtration company.
On January 31, 2017, the General Counsel of the National Labor Relations Board released an official memorandum declaring that scholarship football players at some of the most elite college programs are employees under the National Labor Relations Act.
Arent Fox LLP is pleased to announce the return of health care regulatory attorney Rachel Hold-Weiss as a partner in the firm’s New York office.
Partner Marylee Jenkins, a leader in the New York office’s Intellectual Property group, has been reappointed a member and designated Chairperson of the United States Patent and Trademark Office’s Patent Public Advisory Committee for a three-year term.
New York partner Michelle Marsh was recently quoted in an article by Inside Counsel that explores the trademark infringement lawsuits associated with the Oscars.
On January 20, 2017, President Trump’s Chief of Staff, Reince Priebus, issued a memorandum implementing an immediate regulatory freeze of any new or pending regulations until they have been reviewed and approved by Trump Administration appointees.
An Executive Order from President Trump’s first days in office raised questions about its impact on the hard-won Privacy Shield, which allows about 1,700 companies to legally transfer data between the EEA and Switzerland and the US.
Earlier this month, FDA finalized Guidance for Industry, Assessment of Abuse Potential of Drugs. This guidance is intended to assist researchers and sponsors of new drugs that may have central nervous system (CNS) activity evaluate whether the drug has abuse potential.
The recent Bloomberg BNA article in both the Health Care Daily Report and Medicare Report “Health Fraud Rule Withdrawal May Hurt Enforcement Efforts” discussed how fraud enforcement efforts in the health care industry may be hindered by the Trump Administration.